Imperial Capital Reports Spirit Airlines (SAVE) Downgrade and $42.0000 Target, Shorts at SEVION THERAPEUTICS (SVON) Raised By 37.5%

July 28, 2017 - By Nellie Frank

SEVION THERAPEUTICS INCORPORATED (OTCMKTS:SVON) had an increase of 37.5% in short interest. SVON’s SI was 3,300 shares in July as released by FINRA. Its up 37.5% from 2,400 shares previously. The stock increased 3.25% or $0.009 on July 27, reaching $0.3. About shares traded. Sevion Therapeutics Inc (OTCMKTS:SVON) has 0.00% since July 28, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 12 analysts covering Spirit Airlines (NASDAQ:SAVE), 5 have Buy rating, 0 Sell and 7 Hold. Therefore 42% are positive. Spirit Airlines has $75 highest and $39 lowest target. $63.92’s average target is 59.20% above currents $40.15 stock price. Spirit Airlines had 42 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was maintained by Deutsche Bank with “Buy” on Wednesday, July 12. The stock of Spirit Airlines Incorporated (NASDAQ:SAVE) earned “Neutral” rating by Credit Suisse on Tuesday, April 12. The rating was initiated by JP Morgan with “Overweight” on Thursday, January 14. Cowen & Co maintained the stock with “Outperform” rating in Wednesday, October 28 report. Raymond James downgraded the stock to “Mkt Perform” rating in Friday, October 16 report. Cowen & Co downgraded the stock to “Market Perform” rating in Wednesday, January 4 report. Vetr downgraded it to “Strong-Buy” rating and $69.03 target in Tuesday, August 18 report. The company was downgraded on Friday, October 16 by Morgan Stanley. As per Wednesday, January 20, the company rating was upgraded by Citigroup. The stock of Spirit Airlines Incorporated (NASDAQ:SAVE) has “Buy” rating given on Monday, July 17 by Stifel Nicolaus.

Sevion Therapeutics, Inc. is a development-stage biotech company. The company has market cap of $8.08 million. The Firm is engaged in building and developing a portfolio of therapeutics, from both internal discovery and acquisition, for the treatment of cancer and immunological diseases. It currently has negative earnings. The Firm is engaged in the development and licensing of technology to discover and engineer monoclonal antibodies.

About 911 shares traded. Spirit Airlines Incorporated (NASDAQ:SAVE) has risen 28.69% since July 28, 2016 and is uptrending. It has outperformed by 11.99% the S&P500.

Spirit Airlines, Inc. is an airline company. The company has market cap of $2.78 billion. The Firm provides air transportation for passengers. It has a 11.95 P/E ratio. As of December 31, 2016, its all-Airbus Fit Fleet operated over 420 daily flights to 59 destinations in the United States, Caribbean and Latin America.